Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epigenetic signatures mark early peripheral human B lineage bifurcation and differential transcriptional profiles in mature populations.

Nature communications·2026
Same author

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Nature genetics·2026
Same author

Paediatric therapeutic development workshop on medulloblastoma.

British journal of cancer·2026
Same author

Atlas of human gut-associated lymphoid tissue reveals immunomodulatory interactions of B cells.

Science immunology·2026
Same author

Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies.

Nature communications·2026
Same author

Functional integration of an autologous engineered esophagus in a large-animal model.

Nature biotechnology·2026

相关实验视频

Updated: Sep 9, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K

透露多模式 γδ T 细胞毒性作为克服癌细胞介导免疫调节的策略

Callum Baird Nattress1, Rhianna O'Sullivan1, Daniel Fowler2

  • 1University College London, London, United Kingdom.

Cancer research
|August 29, 2025
PubMed
概括

工程设计的马三角形T细胞使用组合杀伤方法来克服癌症的防御. 这种多模式方法提高了它们消除耐化结直肠癌干细胞的能力, 提供了新的免疫疗法策略.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

670
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

相关实验视频

Last Updated: Sep 9, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

670
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

科学领域:

  • 免疫学和癌症治疗
  • 细胞和分子瘤学

背景情况:

  • 玛三角 (γδ) T 细胞具有双重细胞毒性机制:抗体独立细胞毒性 (AIC) 和抗体依赖细胞毒性 (ADCC).
  • 了解T细胞供体变异性,瘤异质性和γδT细胞杀死之间的相互作用对于推进免疫疗法至关重要.

研究的目的:

  • 调查gδ T细胞的捐赠者间异质性 (IDH) 和结直肠癌 (CRC) 的瘤间异质性 (ITH) 如何影响多模式细胞毒性机制.
  • 评估工程 γδ T 细胞在克服癌细胞介导的免疫逃避方面的有效性.

主要方法:

  • 对1000多种γδT细胞和患者衍生的结肠直肠癌器官 (PDO) 进行系统的单细胞化分析.
  • 对转化后修饰 (PTM) 信号,细胞周期状态,细胞亡和T细胞免疫类型的分析.
  • 使用工程化IL-15Rα-IL-15融合蛋白 (stIL15) γδ T细胞和评估B7-H3向ADCC.

主要成果:

  • 在没有外部细胞因子支持的情况下,工程化stIL15 γδ T细胞对PDOs表现出AIC.
  • 结直肠癌细胞通过以依赖于ITH的方式重新连接γδ T细胞PTM信号网络来适应AIC,抑制细胞毒性.
  • 将AIC与针对B7-H3的ADCC结合,使stIL15 γδ T细胞能够克服癌症诱导的免疫调节,并杀死耐化结肠癌干细胞.

结论:

  • 多模式细胞毒性,结合AIC和ADCC,对于γδT细胞来说至关重要,以克服癌细胞使用的ITH特异性免疫逃避策略.
  • 具有联合细胞毒性机制的工程 γδ T 细胞显示出向耐化癌干细胞的潜力,为新的免疫治疗方法铺平了道路.